Synthesis of Bis-indolylmethane sulfonohydrazides derivatives as potent α-Glucosidase inhibitors. 2018

Mohammed Gollapalli, and Muhammad Taha, and Hayat Ullah, and Muhammad Nawaz, and Laode Muhammad Ramadhan AlMuqarrabun, and Fazal Rahim, and Faiza Qureshi, and Ashik Mosaddik, and Norizan Ahmat, and Khalid Mohammed Khan
Department of Computer Information Systems, College of Computer Science & Information Technology (CCSIT), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.

In search of better α-glucosidase inhibitors, a series of bis-indolylmethane sulfonohydrazides derivatives (1-14) were synthesized and evaluated for their α-glucosidase inhibitory potential. All derivatives exhibited outstanding α-glucosidase inhibition with IC50 values ranging between 0.10 ± 0.05 to 5.1 ± 0.05 μM when compared with standard drug acarbose having IC50 value 856.28 ± 3.15 μM. Among the series, analog 7 (0.10 ± 0.05 μM) with tri-chloro substitution on phenyl ring was identified as the most potent inhibitor of α-glucosidase (∼ 8500 times). The structure activity relationship has been also established. Molecular docking studies were also performed to help understand the binding interaction of the most active analogs with receptors. From the docking studies, it was observed that all the active bis-indolylmethane sulfonohydrazides derivatives showed considerable binding interactions within the active site (acarbose inhibition site) of α-glucosidase. We also evaluated toxicity of all derivatives and found none of them are toxic.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008697 Methane The simplest saturated hydrocarbon. It is a colorless, flammable gas, slightly soluble in water. It is one of the chief constituents of natural gas and is formed in the decomposition of organic matter. (Grant & Hackh's Chemical Dictionary, 5th ed)
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D000520 alpha-Glucosidases Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II. Acid Maltase,Lysosomal alpha-Glucosidase,Maltase,Maltases,Maltase-Glucoamylase,Neutral Maltase,Neutral alpha-Glucosidase,alpha-Glucosidase,Lysosomal alpha Glucosidase,Maltase Glucoamylase,Neutral alpha Glucosidase,alpha Glucosidase,alpha Glucosidases,alpha-Glucosidase, Lysosomal,alpha-Glucosidase, Neutral
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory
D020134 Catalytic Domain The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. Active Site,Catalytic Core,Catalytic Region,Catalytic Site,Catalytic Subunit,Reactive Site,Active Sites,Catalytic Cores,Catalytic Domains,Catalytic Regions,Catalytic Sites,Catalytic Subunits,Core, Catalytic,Cores, Catalytic,Domain, Catalytic,Domains, Catalytic,Reactive Sites,Region, Catalytic,Regions, Catalytic,Site, Active,Site, Catalytic,Site, Reactive,Sites, Active,Sites, Catalytic,Sites, Reactive,Subunit, Catalytic,Subunits, Catalytic

Related Publications

Mohammed Gollapalli, and Muhammad Taha, and Hayat Ullah, and Muhammad Nawaz, and Laode Muhammad Ramadhan AlMuqarrabun, and Fazal Rahim, and Faiza Qureshi, and Ashik Mosaddik, and Norizan Ahmat, and Khalid Mohammed Khan
February 2014, Bioorganic & medicinal chemistry,
Mohammed Gollapalli, and Muhammad Taha, and Hayat Ullah, and Muhammad Nawaz, and Laode Muhammad Ramadhan AlMuqarrabun, and Fazal Rahim, and Faiza Qureshi, and Ashik Mosaddik, and Norizan Ahmat, and Khalid Mohammed Khan
July 2014, Bioorganic & medicinal chemistry,
Mohammed Gollapalli, and Muhammad Taha, and Hayat Ullah, and Muhammad Nawaz, and Laode Muhammad Ramadhan AlMuqarrabun, and Fazal Rahim, and Faiza Qureshi, and Ashik Mosaddik, and Norizan Ahmat, and Khalid Mohammed Khan
October 2013, Carbohydrate research,
Mohammed Gollapalli, and Muhammad Taha, and Hayat Ullah, and Muhammad Nawaz, and Laode Muhammad Ramadhan AlMuqarrabun, and Fazal Rahim, and Faiza Qureshi, and Ashik Mosaddik, and Norizan Ahmat, and Khalid Mohammed Khan
August 2015, Bioorganic & medicinal chemistry,
Mohammed Gollapalli, and Muhammad Taha, and Hayat Ullah, and Muhammad Nawaz, and Laode Muhammad Ramadhan AlMuqarrabun, and Fazal Rahim, and Faiza Qureshi, and Ashik Mosaddik, and Norizan Ahmat, and Khalid Mohammed Khan
December 2010, Journal of medicinal chemistry,
Mohammed Gollapalli, and Muhammad Taha, and Hayat Ullah, and Muhammad Nawaz, and Laode Muhammad Ramadhan AlMuqarrabun, and Fazal Rahim, and Faiza Qureshi, and Ashik Mosaddik, and Norizan Ahmat, and Khalid Mohammed Khan
December 2019, Journal of enzyme inhibition and medicinal chemistry,
Mohammed Gollapalli, and Muhammad Taha, and Hayat Ullah, and Muhammad Nawaz, and Laode Muhammad Ramadhan AlMuqarrabun, and Fazal Rahim, and Faiza Qureshi, and Ashik Mosaddik, and Norizan Ahmat, and Khalid Mohammed Khan
March 2024, Scientific reports,
Mohammed Gollapalli, and Muhammad Taha, and Hayat Ullah, and Muhammad Nawaz, and Laode Muhammad Ramadhan AlMuqarrabun, and Fazal Rahim, and Faiza Qureshi, and Ashik Mosaddik, and Norizan Ahmat, and Khalid Mohammed Khan
August 2017, Bioorganic chemistry,
Mohammed Gollapalli, and Muhammad Taha, and Hayat Ullah, and Muhammad Nawaz, and Laode Muhammad Ramadhan AlMuqarrabun, and Fazal Rahim, and Faiza Qureshi, and Ashik Mosaddik, and Norizan Ahmat, and Khalid Mohammed Khan
March 2024, Molecules (Basel, Switzerland),
Mohammed Gollapalli, and Muhammad Taha, and Hayat Ullah, and Muhammad Nawaz, and Laode Muhammad Ramadhan AlMuqarrabun, and Fazal Rahim, and Faiza Qureshi, and Ashik Mosaddik, and Norizan Ahmat, and Khalid Mohammed Khan
January 2022, Frontiers in chemistry,
Copied contents to your clipboard!